What we do

We develop and apply new methodologies to design drugs with increased efficacy and minimized toxicity

We develop novel in-house methodologies to enhance the effectiveness of established methods and accelerate the drug discovery process using ML-based techniques. The strong integration of computational, synthetic, and medicinal chemistry, with bioevaluation provides us with ongoing feedback that ensures success in the design of molecules with optimal resources.
Our primary focus is on neglected and emerging infectious diseases. We have extensive expertise in the research of diverse targets from Zika and Dengue viruses.

Physics, Chemistry, Biology, and Pharmacology synergistically combined with advanced in silico methods.

© 2024 Meton – All rights reserved.